Pharma Pricing and Market Access USA 2018

Topics

• Important Market Access trends and updates from across the globe
• New reimbursement models which are impacting market access
• Case studies on demonstrating product value
• Hear from leading international HTA agencies
• How to generate , apply and present real world evidence to maximise patient access
• The payers perspective
• Best practice insights for market access of high value and orphan drugs in the multi speaker focus day
• Pricing and partnering models
• Evidence planning and payer strategy for optimum pricing, market access and launch

Who should Attend

Senior attendees with responsibilities in:

• Market Access
• HTA
• Outcomes Research
• Health Economics
• Epidemiology
• Health Policy
• Pharmacoeconomics
• Pricing & Reimbursement
• Clinical research
• Clinical trials
• Medical Affairs
• Post marketing Surveillance
• Pharmacoepidemiology